Please assess the completion status of the following clinical trial:

Trial Title: Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients with proven HIV-1 infection~* Naïve or antiretroviral experienced~* CD4 cell count between 200 and 500/mm3~* Plasma HIV RNA load lower than 4 log10 copies/mL~* Signed written informed consent~Exclusion Criteria:~* Immunotherapy~* Immunization with the PPV within the past 5 years~* Splenectomy~* Use of intravenous immunoglobulin within the past 2 months~* Chemotherapy or radiation~* Any other vaccination within the past 2 months~* Severe renal failure~* End-stage liver disease~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).